Regulatory status raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-22. Anything still debated is marked as such rather than presented as settled.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Marketed for research use in some regions. |
| Human clinical data | Limited or absent | Most evidence is from cell and animal studies. |
| Primary proposed pathway | HGF/c-Met signaling | Angiotensin IV-related activity also reported. |
| Common study models | Rodent neurons and behavioral tasks | Results may not translate directly to humans. |
| Key uncertainty | Bioavailability and brain exposure | Questions remain about absorption and target engagement. |
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
=== Record label signings and dispute over Kendrick Lamar's lyrics === Sometime after deciding to return, Clipse signed to Def Jam Recordings, which had already been Pusha T's label as a solo artist from when GOOD Music was a Def Jam imprint. Let God Sort Em Out was delayed significantly from a planned 2024 release when Def Jam and its parent company Universal Music Group wanted a guest verse by Kendrick Lamar to be censored or removed, initially reported to be because both he and Pusha T have had feuds with Drake, leading to the exchanging of diss tracks in 2018 and 2024, respectively; Universal were said to be uncomfortable with the "optics" of the situation, and Drake's feud with Lamar would eventually result in a lawsuit by Drake against them. It was later clarified that the official reason was use of the phrase "Trump card" in the lyrics and concerns of conflict with United States President Donald Trump, although Pusha T personally believed that this was merely an excuse, as he claimed to have been censored by Def Jam numerous times since 2018 over lyrics that could be perceived as Drake disses. The signing wasn't announced until October 2024. Journalist Elias Leight wrote that the duo was already signed as of "early" 2024. Music industry executive Brian Zisook publicly claimed that Clipse was already under Def Jam c. June 2023. Clipse refused to censor or remove the verse.
=== Video games === Half-Life (1998) Half-Life 2 (2004) Half-Life 2: Episode One (2006) Half-Life 2: Episode Two (2007) Portal (2007) Counter-Strike: Global Offensive (additional music, 2015) Vanishing Realms: Rite of Steel (2016-2019)
== Analytical technologies == In principle, any technologies used for metabolomics can be used for exometabolomics. However, liquid chromatography–mass spectrometry (LC–MS) has been the most widely used. As with typical metabolomic measurements, metabolites are identified based on accurate mass, retention time, and their MS/MS fragmentation patterns, in comparison to authentic standards. Chromatographies typically used are hydrophilic interaction liquid chromatography for the measurement of polar metabolites, or reversed-phase (C18) chromatography for the measurement of non-polar compounds, lipids, and secondary metabolites. Gas chromatography–mass spectrometry can also be used to measure sugars and other carbohydrates, and to obtain complete metabolic profiles. Because LC–MS does not give spatial data on metabolite localization, it can be complemented with mass spectrometry imaging (MSI).
Peter Burke (born 1937) historian, professor and author of over twenty scholarly academic texts and monographs on European history, epistemology, ontology, prisms and perspectives on historiography and ideology; born to Roman Catholic father and Jewish mother (who later converted to Roman Catholicism); was member of School of European Studies at University of Sussex, before moving to University of Cambridge, where he holds title of Professor Emeritus of Cultural History and Fellow of Emmanuel College, Cambridge; celebrated as historian not only of early modern era, but one who emphasises relevance of social and cultural history to modern issues; in 1998, was awarded the Erasmus Medal of the European Academy, and is an honorary doctorate from the Universities of Lund, Copenhagen and Bucharest. Elias Canetti novelist, man of letters, 1981 Nobel Prize (Bulgarian-born); most famous for his work on mass psychology of crowds and anti-fascism, Crowds and Power David Cesarani (13 November 1956 – 25 October 2015) British historian who specialised in Jewish history, especially the Holocaust. He also wrote several biographies, including Arthur Koestler: The Homeless Mind (1998).
Alpha-fetoprotein (AFP) is significantly expressed in foetal liver. However, the mechanism that led to the suppression of AFP synthesis in adults is not fully known. Exposure of the liver to cancer-causing agents and arrest of liver maturation in childhood can lead to the rise in AFP. AFP can reach until 400–500 μg/L in hepatocellular carcinoma. AFP concentration of more than 400 μg/L is associated with greater tumour size, involvement of both lobes of liver, portal vein invasion and a lower median survival rate.
Sources: en.wikipedia.org
Double dilution method can be designed such that the isotopic composition of the two blends, A+B and A*+B, is identical, i.e., RAB = RA*B. This condition of exact-matching double isotope dilution simplifies the above equation significantly:
==== Exact analytical solutions to the SIR model ==== In 2014, Harko and coauthors derived an exact so-called analytical solution (involving an integral that can only be calculated numerically) to the SIR model. In the case without vital dynamics setup, for
=== April === 1 April: The minimum wage rises by 1.5% from $23.15 to $23.50. In addition, training and starting wages rise to $18.80. The Queenstown Lakes District Council strips Councillor Niki Gladding of her roles after she leaked plans by the Council to dump treated effluent into the Shotover River. 3 April – The New Zealand Parliament passes legislation repealing Section 7AA of the Oranga Tamariki Act 1989, which requires Oranga Tamariki (the Ministry of Children) to work in partnership with Māori iwi (tribes) and hapū (sub-groups). 4 April: The Financial Markets Authority commences civil proceedings against insurance company IAG New Zealand for overcharging about 239,000 customers $35 million by incorrectly pricing premiums over the past two decades. The New Zealand Parliament's Justice select committee recommends that the ACT party's contentious Treaty Principles Bill not proceed further following substantial public feedback. The Royal New Zealand Navy's court of inquiry concludes that a series of human errors led to the sinking of HMNZS Manawanui (2019) in early October 2024. 6 April – Several Greenpeace New Zealand protesters occupy part of Port Taranaki to prevent an Indonesian ship carrying palm kernel from unloading. Police arrest four protesters. 7 April: A bomb threat leads to the disruption of proceedings at the Wellington and Palmerston North district courts.
On May 30, 2024, Trump was found guilty by a jury of all 34 felony counts in The People of the State of New York v. Donald J. Trump. The jury found that Trump falsified business records relating to hush money payments made to pornographic film star Stormy Daniels to ensure her silence about a sexual encounter between them. This conviction made Trump the first former U.S. president to be convicted of a crime. On January 10, 2025, Trump was given a no-penalty sentence known as an unconditional discharge. Trump faced other criminal charges as well. In United States of America v. Donald J. Trump, Trump faced four criminal counts for his alleged role in attempting to overturn the 2020 United States presidential election and involvement in the January 6 United States Capitol attack; the case was dismissed following Trump's re-election in November 2024. In The State of Georgia v. Donald J. Trump, et al., Trump was charged with eight criminal counts for his alleged attempts to overturn the results of the 2020 United States presidential election in Georgia. District Attorney Fani Willis was disqualified from prosecuting the case; Willis has appealed that decision. In United States of America v. Donald J. Trump, Waltine Nauta, and Carlos De Oliveira, Trump faced 40 criminal counts relating to his hoarding of classified documents and alleged obstruction of efforts to retrieve them; the case was dismissed in July 2024. On May 9, 2023, in E. Jean Carroll v. Donald J.
In the Earth's crust, the concentration of helium is 8 parts per billion. In seawater, the concentration is only 4 parts per trillion. There are also small amounts in mineral springs, volcanic gas, and meteoric iron. Because helium is trapped in the subsurface under conditions that also trap natural gas, the greatest natural concentrations of helium on the planet are found in natural gas, from which most commercial helium is extracted. The concentration varies in a broad range from a few ppm to more than 7% in a small gas field in San Juan County, New Mexico. As of 2021, the world's helium reserves were estimated at 31,000,000,000 cubic metres (1.1×1012 cu ft), with a third of that being in Qatar. In 2015 and 2016 additional probable reserves were announced to be under the Rocky Mountains in North America and in the East African Rift. The Bureau of Land Management (BLM) has proposed an October 2024 plan for managing natural resources in western Colorado. The plan involves closing 543,000 acres to oil and gas leasing while keeping 692,300 acres open. Among the open areas, 165,700 acres have been identified as suitable for helium recovery. The United States possesses an estimated 8.7×109 m3 (306,000,000,000 cu ft) of recoverable helium, sufficient to meet current consumption rates of 61,000,000 m3 (2,150,000,000 cu ft) per year for approximately 150 years.
Sources: en.wikipedia.org
Examples include the lateral femoral cutaneous nerve at the inguinal ligament and the middle cluneal nerves at the long posterior sacroiliac ligament. The compression even be dynamic, where compression may only be present during certain activities and positions. In deep gluteal syndrome, patients often have sciatic radiculopathy when sitting but not standing. Studies on compression and nerve function have found a dose-respondent relationship between pressure and duration. That is higher pressures and longer duration are associated with greater dysfunction. However even short but repeated periods of compression can also damage a nerve's microcirculatory environment. The amount of pressure required to cause nerve dysfunction starts at around 20mmHg where epineural venus blood flow is reduced. At 30mmHg anterograde and retrograde axonal transport is impaired. Between 30-50mmHg there will usually be changes in intraneural blood flow, axonal transport, and vascular permeability simultaneously. And at 80mmHg all intraneural blood flow is arrested, which results in a complete metabolic block. The amount of pressure required to disrupt intraneural blood flow isn't an absolute pressure but rather a function of the arterial blood pressure and perfusion pressure. Patients with higher blood pressures are somewhat protected from the effects of nerve entrapment by requiring higher pressures to interrupt intraneural blood flow.
At low glucose levels, the production of acetyl-CoA is linked to β-oxidation of fatty acids. Fatty acids are first converted to acyl-CoA. Acyl-CoA is then degraded in a four-step cycle of oxidation, hydration, oxidation and thiolysis catalyzed by four respective enzymes, namely acyl-CoA dehydrogenase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and thiolase. The cycle produces a new fatty acid chain with two fewer carbons and acetyl-CoA as a byproduct. Within mitochondria, MCD similarly facilitates acetyl-CoA production by decarboxylating malonyl-CoA, thereby supporting metabolic flexibility during low-glucose states.
== History == SOLAR began in 1975 as Soul Train Records, founded by Dick Griffey and Soul Train creator Don Cornelius. The first act they signed was an R&B vocal quartet they named The Soul Train Gang (Gerald Brown, Terry Brown, Judy Jones, Patricia Williamson, and later Denise Smith), who performed one of Soul Train's many themes, "Soul Train '75". Their first album was entitled Don Cornelius Presents The Soul Train Gang. In 1976, their second album, The Soul Train Gang, produced by Philly's Norman Harris, was released. The Gang broke up in 1977. That same year, singer/drummer Arnie Oliver, aka Ahaguna G. Sun, and singer/guitarist Werner "Bear" Schuchner formed Sunbear, a little-known soul/funk vocal duo that recorded in Los Angeles in 1977. Earth, Wind & Fire was a heavy influence on Sunbear, and there were also hints of Tower of Power and El Chicano in their sound. In 1977, Sunbear recorded its self-titled debut album for Don Cornelius and Dick Griffey's Soul Train Records, which evolved into Solar Records after Cornelius' departure in 1978. Sunbear broke up without ever recording a second album, and Oliver and Schuchner both went on to pursue other activities in the R&B world. Oliver became a member of Frankie Beverly's Maze, while Schuchner played guitar on albums by the Whispers, the Soul Train Gang, High Inergy, and others. In 1980, the Whispers recorded Sunbear's ballad "Fantasy" for their hit album Imagination. Griffey formed a collective called Shalamar, using a host of session singers to record "Uptown Festival," a disco-length medley of early Motown hits.
== Bronchodilators == Arformoterol Bitolterol Epinephrine Fenoterol Formoterol Ipratropium Isoetharine Isoproterenol Levalbuterol Metaproterenol Pirbuterol Procaterol Racepinephrine (racemic epinephrine) Salbutamol Salmeterol Terbutaline Tiotropium
Addiction is a serious risk with heavy recreational amphetamine use, but is unlikely to occur from long-term medical use at therapeutic doses; in fact, lifetime stimulant therapy for ADHD that begins during childhood reduces the risk of developing substance use disorders as an adult. Pathological overactivation of the mesolimbic pathway, a dopamine pathway that connects the ventral tegmental area to the nucleus accumbens, plays a central role in amphetamine addiction. Individuals who frequently self-administer high doses of amphetamine have a high risk of developing an amphetamine addiction, since chronic use at high doses gradually increases the level of accumbal ΔFosB, a "molecular switch" and "master control protein" for addiction. Once nucleus accumbens ΔFosB is sufficiently overexpressed, it begins to increase the severity of addictive behavior (i.e., compulsive drug-seeking) with further increases in its expression. While there are currently no effective drugs for treating amphetamine addiction, regularly engaging in sustained aerobic exercise appears to reduce the risk of developing such an addiction. Exercise therapy improves clinical treatment outcomes and may be used as an adjunct therapy with behavioral therapies for addiction.
Sources: en.wikipedia.org
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.
Preclinical research has focused on synaptic growth, cognitive performance in animals, and HGF/c-Met signaling. These are experimental findings, not established treatments.
Legality varies by country and intended use. It is commonly sold as a research chemical, and sales for human consumption may be restricted. Local regulations should be checked.
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.